Bioxytran, Inc.
BIXT
$0.077
-$0.0068-8.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.80% | 31.26% | 52.45% | 37.55% | -9.51% |
| Total Depreciation and Amortization | -3.30% | -20.41% | -4.82% | 62.96% | 102.22% |
| Total Amortization of Deferred Charges | 2,059.33% | 94.43% | 94.43% | -84.55% | -94.32% |
| Total Other Non-Cash Items | -32.38% | 28.23% | 187.54% | 4.58% | 2,607.76% |
| Change in Net Operating Assets | -55.98% | -50.03% | -70.75% | -26.42% | 54.44% |
| Cash from Operations | 71.76% | 76.61% | 86.38% | 71.14% | 49.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.97% | 55.04% | 40.18% | 47.24% | 29.31% |
| Cash from Investing | -47.97% | 55.04% | 40.18% | 47.24% | 29.31% |
| Total Debt Issued | 82.12% | 15.68% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -88.55% | -88.55% | -90.89% | -37.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.17% | -70.31% | -79.81% | -62.83% | -23.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.51% | 96.11% | 92.24% | 84.48% | 93.04% |